During the past decade, The Memory Clinic conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 19 clinical trials were completed, i.e. on average, 86.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Memory Clinic" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 6 trials sponsored, "Biogen" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "AstraZeneca" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Memory Clinic" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 4 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "The Memory Clinic" are "Alzheimer's Disease" (19 trials), "Alzheimer Disease" (18 trials), "Alzheimers Disease" (2 trials), "Dementia" (2 trials) and "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "The Memory Clinic" in a lesser frequency.

Most popular intervention types in "The Memory Clinic" are "Drug" (38 trials), "Biological" (4 trials), "Other" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Donanemab" (3 trials), "Placebo Control" (3 trials), "bapineuzumab" (3 trials) and "Aducanumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Memory Clinic" are 44 trials for "All" genders.

Currently, there are NaN active trials in "The Memory Clinic". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in The Memory Clinic, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in The Memory Clinic, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".